Literature DB >> 9418012

Purification and characterization of equine testicular cytochrome P-450 aromatase: comparison with the human enzyme.

S Moslemi1, A Vibet, V Papadopoulos, L Camoin, P Silberzahn, J L Gaillard.   

Abstract

Cytochrome P-450 aromatase was purified by five chromatographic steps from adult stallion testis. It was first separated from NADPH-cytochrome P-450 reductase (reductase) on omega-aminohexyl-Sepharose 4B then purified to homogeneity on concanavalin A-Sepharose 4B, hydroxyapatite-Sepharose 4B, DEAE-Sepharose CL-6B and on a second hydroxyapatite-Sepharose 4B. On the other hand, purifications of the equine testicular and rat liver reductases, which allowed the reconstitution of aromatase activity in vitro, were achieved for each species in one chromatographic step on an adenosine 2',5'-diphosphate-agarose affinity column. Analysis on SDS/PAGE indicated single bands with apparent molecular masses of 53, 82, and 80 kDa for purified equine testicular cytochrome P-450 aromatase (eAROM), equine testicular reductase and rat liver reductase respectively. eAROM shows a time- and concentration-dependent activity that was stable for at least 2 months when stored at -78 degrees C. It is a highly hydrophobic protein composed from 505 residues and direct sequencing of its N-terminal part showed good homology when compared with human aromatase. When deglycosylated by N-glycosidase-F the apparent molecular mass of eAROM was decreased from 53 to 51 kDa as revealed by electrophoresis, its activity, however, was not impaired. eAROM exhibits much higher affinity for androgens than for 19-norandrogens, Km values were approximately 3, 16 and 170 nM for androstenedione (A), testosterone (T) and 19-nortestosterone (19-NT) respectively. However, it aromatizes 19-norandrostenedione (19-NA) slightly more efficiently than A, the estrone (E1) formed was 4.27 vs 3.54 pmol min-1 micrograms-1 respectively (P < 0.01). After incubation of eAROM with radiolabelled A and separation of steroids on HPLC, E1, 19-hydroxyandrostenedione (19-OHA) and 19-oxoandrostenedione (19-oxoA) were accumulated in the incubation medium in a time-dependent manner. The presence of 4-hydroxyandrostenedione (4-OHA), a suicide inhibitor of aromatase, cause a time-dependent inactivation of the enzyme. Whereas the activity of eAROM was unchanged in the presence of K+ (up to 250 mM), it was increased in the presence of EDTA (up to 50 mM) and decreased in the presence of DTT or Mg2+ (from 25 mM). We conclude that: (a) eAROM is a glycoprotein, however, deglycosylation by N-glycosidase-F does not appear to impair its activity, (b) eAROM aromatizes really both androgens and 19-norandrogens having a higher affinity for androgens, (c) the intermediary compounds of aromatization 19-OHA and 19-oxoA appear to be synthesized by the same active site that synthesizes E1 as the final product, (d) the inhibition of eAROM by increasing concentrations of Mg2+ and the stimulation of its activity by EDTA, taken together, indicate the importance of negatively charged residues in the polypeptide chain of equine aromatase, which play a role in enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418012     DOI: 10.1016/s0305-0491(97)00033-3

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  3 in total

1.  Aromatase is phosphorylated in situ at serine-118.

Authors:  Todd W Miller; Incheol Shin; Norio Kagawa; Dean B Evans; Michael R Waterman; Carlos L Arteaga
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-04       Impact factor: 4.292

2.  Differential effects of glyphosate and roundup on human placental cells and aromatase.

Authors:  Sophie Richard; Safa Moslemi; Herbert Sipahutar; Nora Benachour; Gilles-Eric Seralini
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

3.  Expression of aromatase and estrogen receptors in human adrenocortical tumors.

Authors:  Luisa Barzon; Giulia Masi; Monia Pacenti; Marta Trevisan; Francesco Fallo; Andrea Remo; Guido Martignoni; Daniela Montanaro; Vincenzo Pezzi; Giorgio Palù
Journal:  Virchows Arch       Date:  2007-12-21       Impact factor: 4.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.